Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
₹7232 Cr.
Stock P/E
251.5
P/B
4.5
Current Price
₹2407.1
Book Value
₹ 530.6
Face Value
10
52W High
₹2498.5
52W Low
₹ 978
Dividend Yield
0.04%

Neogen Chemicals Overview

Business

Neogen Chemicals Ltd. is an Indian specialty chemicals manufacturer focusing on bromine-based and lithium-based advanced intermediates. The company develops and manufactures specialty organic chemicals, inorganic chemicals, and pharmaceutical intermediates. Its products serve diverse end-user industries including pharmaceuticals, agrochemicals, engineering, electronic chemicals, battery chemicals, and construction chemicals. Neogen operates on a business-to-business (B2B) model, providing customized and complex chemical solutions to its clients, thereby making money through the sale of these specialty chemical products.

Revenue Mix

Neogen's business is primarily divided into:

Bromine-based Specialty Chemicals: This segment includes a wide range of organic and inorganic bromine compounds used in pharmaceuticals, agrochemicals, flame retardants, and other industrial applications.

Lithium-based Specialty Chemicals: This segment focuses on lithium salts and derivatives, which are crucial components, particularly for the rapidly growing lithium-ion battery market (Electric Vehicles, energy storage) and also in pharmaceutical synthesis.

While specific real-time revenue contributions vary, both segments are strategic, with lithium-based chemicals expected to be a significant growth driver due to their application in new-age technologies.

Industry

Neogen operates within the Indian specialty chemicals industry, a sector characterized by high entry barriers due to complex manufacturing processes, specific client approvals, and R&D intensity. The industry benefits from global supply chain diversification away from China (China+1 strategy) and strong domestic demand. Neogen is positioned as a niche player specializing in complex bromine and lithium chemistries, which gives it an edge over generic chemical manufacturers. Its focus on import substitution and catering to critical industries like pharmaceuticals and EV batteries places it in a high-growth sub-segment.

MOAT

Neogen's competitive advantages include:

Niche Expertise & R&D: Deep expertise in bromine and lithium chemistry allows it to develop and manufacture complex, high-value-added products that require specialized knowledge and processes. This creates barriers for new entrants.

Long-standing Customer Relationships & Approvals: Building trust and securing approvals from global pharmaceutical and industrial clients takes years, leading to sticky customer relationships and preferred supplier status.

Custom Synthesis Capabilities: Ability to offer custom synthesis and contract manufacturing services for specific client requirements, which fosters client dependence and repeat business.

Process Know-how: Proprietary manufacturing processes and safety protocols for handling hazardous chemicals like bromine.

Growth Drivers

Key factors that can drive Neogen's growth include:

Electric Vehicle (EV) Adoption: Rapid global and domestic adoption of EVs will significantly boost demand for lithium-ion batteries and, consequently, Neogen's lithium-based chemicals.

"China+1" Strategy: Global supply chain de-risking benefits Indian specialty chemical manufacturers as global companies seek alternative sourcing options.

Capacity Expansion: Ongoing capital expenditure plans to expand manufacturing capacities for both existing and new product lines, particularly in lithium-ion battery chemicals.

New Product Development & Import Substitution: Continuous R&D efforts to develop new, advanced specialty chemicals and substitute imported products, expanding market reach and reducing reliance on imports.

Growth in End-User Industries: Sustained growth in pharmaceuticals, agrochemicals, and other industrial sectors globally and domestically.

Risks

Raw Material Price Volatility: Dependence on imported and domestically sourced raw materials like bromine and various lithium salts, whose prices are subject to global supply-demand dynamics and currency fluctuations.

Intense Competition: Competition from established domestic and international specialty chemical players, particularly from China.

Technological Obsolescence: Rapid advancements in battery technology or chemical synthesis processes could potentially render some current product lines less competitive.

Environmental & Regulatory Risks: Strict environmental regulations and the hazardous nature of chemicals handled require continuous compliance and investment in safety measures.

Customer Concentration: While not explicitly high, dependence on a few large clients in niche segments could pose a risk if business from them declines.

Project Execution Risk: Delays or cost overruns in ongoing capacity expansion projects could impact financial performance.

Management & Ownership

Neogen Chemicals is promoted by the Haria family, with Mr. Harin Kanani as the Managing Director. The promoters have a deep understanding of the chemical industry, having been involved in the business for several decades. The management team generally comprises experienced professionals in chemistry, operations, and finance. The promoter group holds a significant stake in the company, aligning their interests with those of public shareholders. Institutional investors also hold a notable portion, indicating confidence in the company's prospects.

Outlook

Neogen Chemicals is well-positioned in the growing Indian specialty chemicals sector, particularly benefiting from the structural tailwinds of global supply chain diversification and the burgeoning demand for lithium-ion battery chemicals. The company's niche expertise in complex chemistries and focus on R&D provides a solid foundation for growth. The increasing adoption of EVs and energy storage solutions presents a significant long-term opportunity for its lithium-based products. However, the company faces risks from raw material price volatility, intense competition, and the execution of its ambitious capacity expansion plans. While the long-term growth trajectory appears favorable due to its strategic focus and strong market positioning, successful execution of projects and efficient management of raw material costs will be crucial for sustained profitability.

Neogen Chemicals Share Price

Live · BSE / NSE · Inception: 1989
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Neogen Chemicals Quarterly Results

#(Fig in Cr.) Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 200 180 193 201 203 187 209 220 247 250
Other Income 2 2 1 1 1 1 2 2 1 4
Total Income 202 182 194 202 203 188 211 222 248 254
Total Expenditure 164 149 159 167 166 155 179 188 203 202
Operating Profit 38 32 35 36 37 33 32 34 45 52
Interest 10 10 13 13 13 13 19 22 21 21
Depreciation 6 7 7 7 7 6 7 7 8 8
Exceptional Income / Expenses 0 0 0 0 -14 0 0 0 0 0
Profit Before Tax 22 16 15 15 4 14 5 6 16 23
Provision for Tax 6 4 5 5 1 4 2 2 4 6
Profit After Tax 17 11 11 10 2 10 3 4 11 17
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 17 11 11 10 2 10 3 4 11 17
Adjusted Earnings Per Share 6.4 4.3 4.2 3.8 0.9 3.9 1.3 1.4 4.3 6.2

Neogen Chemicals Profit & Loss

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Net Sales 100 110 161 239 306 336 487 686 691 778 862 926
Other Income 0 0 1 1 0 0 1 4 7 4 6 9
Total Income 100 110 162 240 306 337 488 691 698 782 868 935
Total Expenditure 86 90 132 196 248 272 401 575 581 641 725 772
Operating Profit 14 20 30 44 58 65 88 116 118 140 143 163
Interest 5 8 10 12 12 14 19 29 42 49 75 83
Depreciation 1 1 2 3 5 7 12 16 23 28 28 30
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 -14 0 0
Profit Before Tax 8 11 17 29 41 44 57 71 53 50 41 50
Provision for Tax 3 4 6 8 12 13 12 21 17 15 12 14
Profit After Tax 5 8 11 21 29 31 45 50 36 35 29 35
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 5 8 11 21 29 31 45 50 36 35 29 35
Adjusted Earnings Per Share 2.6 3.8 5.5 10.4 12.3 13.4 17.9 20 13.5 13.2 10.9 13.2

Neogen Chemicals Balance Sheet

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Shareholder's Funds 28 42 50 70 156 183 439 483 760 789 816
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 5 37 38 51 30 116 122 129 124 170 819
Other Non-Current Liabilities 3 7 8 9 18 15 20 32 50 54 79
Total Current Liabilities 46 67 84 117 150 178 218 410 527 733 1188
Total Liabilities 80 152 180 246 355 492 799 1054 1461 1747 2902
Fixed Assets 17 56 67 83 111 127 285 347 496 404 475
Other Non-Current Assets 2 6 7 4 13 125 22 51 182 344 1035
Total Current Assets 61 90 107 160 231 240 492 656 784 1000 1393
Total Assets 80 152 180 246 355 492 799 1054 1461 1747 2902

Neogen Chemicals Cash Flow

#(Fig in Cr.) Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Opening Cash & Cash Equivalents 2 2 3 2 2 1 1 45 21 13 5
Cash Flow from Operating Activities 9 0 12 -4 -35 84 1 -30 -29 196 -231
Cash Flow from Investing Activities -4 -33 -13 -20 -29 -135 -146 -94 -216 -317 -410
Cash Flow from Financing Activities -4 33 -0 24 63 51 188 100 237 113 642
Net Cash Inflow / Outflow 0 1 -1 0 -1 -0 44 -25 -8 -8 -0
Closing Cash & Cash Equivalent 2 3 2 2 1 1 45 21 13 5 5

Neogen Chemicals Ratios

# Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Earnings Per Share (Rs) 2.59 3.84 5.49 10.43 12.28 13.43 17.89 20.04 13.51 13.2 10.9
CEPS(Rs) 3.09 4.48 6.42 11.85 14.53 16.39 22.58 26.53 22.18 23.74 21.33
DPS(Rs) 0.45 0 1 1.5 2 2.25 2.75 3 2 1 1
Book NAV/Share(Rs) 13.77 20.98 25.21 34.96 66.96 78.44 176.12 193.47 288.21 299.24 309.43
Core EBITDA Margin(%) 12.96 16.45 17.68 16.99 16.7 16.06 17.77 16.27 15.83 17.44 15.89
EBIT Margin(%) 12.19 15.63 16.98 16.12 15.25 14.47 15.63 14.57 13.64 12.62 13.45
Pre Tax Margin(%) 7.79 9.44 10.62 11.45 11.82 11.03 11.71 10.35 7.59 6.42 4.75
PAT Margin (%) 4.76 6.29 6.7 8.2 8.24 7.82 9.16 7.28 5.13 4.46 3.33
Cash Profit Margin (%) 5.68 7.37 7.83 9.31 9.75 9.54 11.56 9.64 8.42 8.01 6.51
ROA(%) 6.94 6.57 6.6 9.81 9.53 7.4 6.91 5.39 2.83 2.17 1.24
ROE(%) 20.3 22 23.78 34.73 25.31 18.47 14.34 10.84 5.74 4.5 3.58
ROCE(%) 26.11 23.01 22.85 25.52 21.93 16.75 14.33 13.25 9.49 7.86 6.64
Receivable days 56.68 72.13 81.81 72.86 71.35 70.02 70.43 76.3 120.51 112.52 122.62
Inventory Days 93.95 107.83 100.15 87.39 106.19 111.05 115.59 129.67 177.31 161.47 185.31
Payable days 114.11 150.54 130.19 103.11 77.99 94.13 109.49 119.98 143.69 175.91 275.96
PER(x) 0 0 0 0 28.59 64.36 97.51 64.03 88.26 117.02 102.04
Price/Book(x) 0 0 0 0 5.24 11.02 9.91 6.63 4.14 5.16 3.59
Dividend Yield(%) 0 0 0 0 0.57 0.26 0.16 0.23 0.17 0.06 0.09
EV/Net Sales(x) 0.44 0.78 0.62 0.58 3.12 6.63 9.3 5.16 5.11 5.96 4.94
EV/Core EBITDA(x) 3.08 4.24 3.39 3.14 16.42 34.59 51.69 30.51 30.02 33.04 29.69
Net Sales Growth(%) 19.52 9.74 46.41 48.34 28.05 9.89 44.84 40.83 0.65 12.58 10.85
EBIT Growth(%) 4.35 43.04 46.66 47.95 28.72 9.35 31.34 31.28 -5.14 4.04 17.77
PAT Growth(%) 1.87 47.59 43.68 90.7 36.81 9.33 42.45 11.97 -28.66 -2.3 -17.46
EPS Growth(%) 1.77 48.32 42.97 89.94 17.72 9.35 33.25 11.97 -32.55 -2.3 -17.46
Debt/Equity(x) 0.96 1.65 1.63 1.71 0.88 1.18 0.51 0.75 0.52 0.72 1.63
Current Ratio(x) 1.34 1.35 1.28 1.37 1.54 1.35 2.26 1.6 1.49 1.36 1.17
Quick Ratio(x) 0.64 0.75 0.68 0.75 0.68 0.71 1.36 0.89 0.76 0.94 0.69
Interest Cover(x) 2.77 2.53 2.67 3.45 4.45 4.21 3.99 3.45 2.25 2.03 1.55
Total Debt/Mcap(x) 0 0 0 0 0.17 0.11 0.05 0.11 0.13 0.14 0.45

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +11% +8% +21% +24%
Operating Profit CAGR +2% +7% +17% +26%
PAT CAGR -17% -17% -1% +19%
Share Price CAGR +59% +11% +14% —
ROE Average +4% +5% +8% +17%
ROCE Average +7% +8% +10% +17%

Neogen Chemicals Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 53.01 %
FII 4.11 %
DII (MF + Insurance) 19.6 %
Public (retail) 23.28 %
# Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Promoter 56.8956.8951.2351.2351.2351.2351.2351.2351.2353.01
FII 4.564.658.177.737.797.365.154.574.464.11
DII 22.1422.5422.4822.5322.7522.9625.2321.9922.6419.6
Public 16.4115.9218.1218.5118.2318.4518.3922.2121.6723.28
Others 0000000000
Total 100100100100100100100100100100

Neogen Chemicals Peer Comparison

Chemicals Edit Columns

Neogen Chemicals Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Neogen Chemicals Pros & Cons

Pros

Cons

  • Company has a low return on equity of 5% over the last 3 years.
  • Debtor days have increased from 175.91 to 275.96days.
  • Stock is trading at 4.5 times its book value.
  • The company has delivered a poor profit growth of -1% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp